“Low Dose Naltrexone (LDN) is a drug that is credited with helping those with HIV/AIDS, cancer, autoimmune diseases, and central nervous system disorders (including MS) by boosting (modulating) the immune system. As well as being effective it is cheap, costing less than one pound a day, and could save the NHS vast sums of money. We therefore urge the Govenment to fund a trial of LDN on the NHS so that everyone in the UK can reap the benefits of this drug.” Stephen Crabb MP
Patients in the 21st century are well informed. When we take a lead and use a drug in large numbers by choice, if that drug needs clinical trials to be accepted, this patient demand must trigger trials to be urgently commissioned. This capability is missing from our research systems and needs implementation. We patients are capable of indicating new areas for research as much as academia, because we read and have vested interested in getting our ideas right. So, we practice theoretical medicine on ourselves, supported by doctors and scientists, to try and help ourselves, and that is good enough to drive research trials when they are required. Informed patient driven research now, starting with LDN! Especially when you also consider the potential for saving the NHS tens of millions of pounds in drug fees.
NEWS:: The debate in the House of Commons has been very successful - the debate transcript - and has defined in parliament the whole debate for legitimization of LDN. We now have a large and growing support from MP's to form an All Party Parliamentary Group. Enjoy the transcript, also a video recording
LDN is not a miracle drug as many seem determined to claim, it is in fact a drug that implements the biotherapy approach to medicine, which is all about artificially stimulating the bodies own defenses and systems in order to restore control over systemic diseases. This control is how most people remain clear of these diseases in normal health. The immune system we have has evolved over billions of years and does many jobs far better than our modern, symptom relief drug culture ever can.
LDNNow campaign with Nia Griffith hits the radio - Listen Here
Letter to your MP to support the petition to the House of Commons. Please download and use to write to your MP. Feel free to personalise this letter too. This petition process has now progressed to suporting a petition for a debate in the house, which can happen soon if we have enough momentum, so we need as many MP's as possible to rally behind this debate.
Please sign the EU petition. The EU petition takes this issue to the point about human rights. We feel that a person who requests LDN as a safe option should be able to get it easily. It is often the sick themselves who know what they need. But we also request that they make the research a reality, not just a notion assuming someone will do it eventually.
Video from LDNScience - How LDN Works - LDNscience™ – Communicating all the scientific research and rationale for Low Dose Naltrexone (LDN), Opioid Growth Factor (OGF) and related therapies. LDNscience™ is a project of the MedInsight® Research Institute.at LDNScience.org.
If you are looking to contribute money towards the research into LDN nd OGF with Dr Zagon and LDNScience, this can be done via the following contact - Jerry L. Alberts - Executive Director of Individual Gifts. This is vital ow because the US government funds for this work are drying up and a lot of resarch is being done right now.
Donations can go to: Name: JERRY LEON ALBERTS E-mail:jla32@psu.edu Mail ID: jla32@psu.edu Address: A120 HERSHEY HERSHEY MEDICAL CENTER Telephone Number: +1 717 531 8456 Title: EXEC DIR OF UNIV DEVEL Administrative Area: DEV & ALUMNI RELATIONS Department: HERSHEY
LDN and OGF research is funded partly by Penn State, partly by Dr Zagon and his colleagues and partly by donations. Since government funding is drying up due to the world economic crisis, donations are now more vital, and we are curreently encouring everyone, including suppliers of LDN, to support this initiative to get funds to Dr Zagon to keep this research going. There has been a large number of publications in the last year, and we need more. See LDNScience for details.
Dr Chris Steele MBE from ITV 'This Morning" supports the LDN petition on YouTube, seen here handing in the petition to number 10 Downing Street with 13028 signatures. The response once again points us at the government sponsored body NIHR Health Technology Assessment programme, a body established to fund and pursue research which cannot find funding commercially. We have asked them for research on use as a front line, first do no harm, and safe therapy, for use with Cancer and autoimmune diseases. As versatile as steroids, but without the bad side effects! Remember, first of all, LDN is safe, and if a rebalanced immune system was a problem to people with autoimmune diseases, then how come all us LDN users are doing so well?
The petition to number 10 in one year, achieved 13028 signatures demanding that the government funds the trials for Low Dose Naltrexone for the diseases that it treats if that is what is required to make it available on the NHS as a front line, 'first do no harm' treatment option for diseases like CANCER, MS, RHEUMATOID ARTHRITIS, HIV/AIDS and Autoimmune conditions in general and even INFERTILITY requiring IVF! and more besides.
The application for research at NIHR has been considered and the response now is much more positive and helpful. We have established a definite way forward but there is still no guarantee of success. However, thankyou to NIHR for their help in this matter and their openness.
If you are looking to contribute money towards the research into LDN nd OGF with Dr Zagon and LDNScience, this can be done via the following contact - Jerry L. Alberts - Executive Director of Individual Gifts. This is vital ow because the US government funds for this work are drying up and a lot of resarch is being done right now.